Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED | N.MMED.WA | N.MMED.WR | N.MMED.WS

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Post by TAPickson Apr 11, 2011 8:11am
433 Views
Post# 18412326

Moves above 200 SMA

Moves above 200 SMA

Brigus Gold is again on my radar screen as a potential 200 SMA pop and a break of the downtrend. Friday's high volume came in around noon as the price moved 2% above the 200 SMA at $1.58, but volume tapered off in the afternoon so I'm not sure if this was automatic trading or not that triggered the buying. In any case, it closed above the 200 SMA but did not close above my resistance line at $1.60. Monday should be an interesting day for it. Should it move above the $1.60 resistance line I think this would be a good entry and the stop loss would be the 200 SMA line.

I expect to see the next resistance line at $1.77 as the first target for Brigus giving us gains of 10.6%. Second target is the psychological resistance of $2.00 (remember that round numbers often form resistance/support areas) for gains of 25%.

See chart https://us1.campaign-archive1.com/?u=4d6d491aea8e01d93d8a1f390&id=b285737b82#BRD
For other weekly picks see https://www.ta-picks.com/WeeklyPicks.html

Cheers!

Bullboard Posts